March 3 2015 Latest news:
Monday, June 16, 2014
Majestic Wine posted broadly flat profits of £23.8 million today as the retailer counted the cost of a New Year hangover in consumer spending.
The wine warehouse chain, which has 206 stores in the UK, described trading conditions as challenging and said its rate of online growth had slowed due to new entrants into the market.
Total sales rose 1.4pc to £278.2 million in the year to March 31 but like-for-like sales were 0.1pc lower due to a poor January and February as consumer spending was subdued following a positive Christmas trading period.
Majestic said: “The market in which we operate remains very competitive and is dominated by the large supermarkets. The market has declined slightly in volume terms over each of the last three years although it has continued to grow modestly in value.”
It blamed inflationary pressures on alcohol duties which have risen from £1.81 per bottle three years ago to £2.05. Costs have also been rising around the world as harvests have been weaker due to poor weather combined with rising demand particularly in the Far East.
Majestic said its share of the market as measured by Nielsen increased by 0.1pc to 4.2pc over the year to the end of March.
The average bottle price of still wine purchased at Majestic rose to £7.94, up from £7.56 last year whilst average spend per transaction increased by £1 to £129. It achieved an increase in the number of active customers who made purchases in the last twelve months to 643,000, up 2.9pc on last year.
The retailer reported a significant lift in sales of Rose from Provence up 84pc and Malbec from Argentina, Chile and France up 50pc. Sales of still wine priced at £20 per bottle and above grew 19.7pc to £18.7 million.
Majestic said it continued to see the opportunity to increase the size of its retail estate to around 330 locations nationwide. A new distribution facility is expected to be fully operational by the end of this month.
With a reputation as one of the toughest people in business, many stores would shudder at the thought of getting the Mary Portas treatment.